 | • レポートコード：MRC-IM30426 • 出版社/出版日：IMARC / 2022年11月 • レポート形態：英文、PDF、145ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥374,850 (USD2,499) | ▷ お問い合わせ |
| Enterprisewide | ￥674,850 (USD4,499) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| IMARC社の調査レポートによると、世界の哺乳類ポリクローナルIgG抗体市場規模は2021年に984.81百万ドルに達しました。今後、2027年には1,351.73百万ドルになり、2022年から2022年の間に年平均5.25％成長すると予測しています。本調査レポートでは、哺乳類ポリクローナルIgG抗体の世界市場について調査・分析を行い、序論、調査範囲・手法、エグゼクティブサマリー、イントロダクション、種類別（ヤギ、ウサギ、馬、マウス、その他）分析、製品別（心臓マーカー、代謝マーカー、腎マーカー、その他）分析、用途別（ELISA、免疫比濁法、免疫電気泳動、免疫組織化学、その他）分析、エンドユーザー別（病院、診断センター、学術＆研究機関）分析、地域別（北米、アジア、欧州、中南米、中東・アフリカ）分析、SWOT分析（強み・弱み・機会・脅威）、バリューチェーン分析、ファイブフォース分析、価格分析、競争状況などを掲載しています。なお、企業情報には、Abbiotec Inc., Abcam plc, Bio-Rad Laboratories Inc., Cell Signaling Technology Inc., Creative Diagnostics, Elabscience Biotechnology Inc., Geno Technology Inc., Merck KGaA, Proteintech Group Inc., STEMCELL Technologies Inc. and Thermo Fisher Scientific Inc.などが含まれています。 ・序論 ・調査範囲・手法 ・エグゼクティブサマリー ・イントロダクション ・世界の哺乳類ポリクローナルIgG抗体市場規模：種類別 - ヤギにおける市場規模 - ウサギにおける市場規模 - 馬における市場規模 - マウスにおける市場規模 - その他種類における市場規模 ・世界の哺乳類ポリクローナルIgG抗体市場規模：製品別 - 心臓マーカーの市場規模 - 代謝マーカーの市場規模 - 腎マーカーの市場規模 - その他製品の市場規模 ・世界の哺乳類ポリクローナルIgG抗体市場規模：用途別 - ELISA用哺乳類ポリクローナルIgG抗体の市場規模 - 免疫比濁法用哺乳類ポリクローナルIgG抗体の市場規模 - 免疫電気泳動用哺乳類ポリクローナルIgG抗体の市場規模 - 免疫組織化学用哺乳類ポリクローナルIgG抗体の市場規模 - その他用途の市場規模 ・世界の哺乳類ポリクローナルIgG抗体市場規模：エンドユーザー別 - 病院における市場規模 - 診断センターにおける市場規模 - 学術＆研究機関における市場規模 ・世界の哺乳類ポリクローナルIgG抗体市場規模：地域別 - 北米の哺乳類ポリクローナルIgG抗体市場規模 - アジアの哺乳類ポリクローナルIgG抗体市場規模 - 欧州の哺乳類ポリクローナルIgG抗体市場規模 - 中南米の哺乳類ポリクローナルIgG抗体市場規模 - 中東・アフリカの哺乳類ポリクローナルIgG抗体市場規模 ・SWOT分析（強み・弱み・機会・脅威） ・バリューチェーン分析 ・ファイブフォース分析 ・価格分析 ・競争状況 |
The global mammalian polyclonal IgG antibody market size reached US$ 984.81 Million in 2021. Looking forward, IMARC Group expects the market to reach US$ 1,351.73 Million by 2027, exhibiting a growth rate (CAGR) of 5.25% during 2022-2027.
Mammalian polyclonal immunoglobulins (IgG) antibody refers to antigens or vaccinations that are manufactured through inoculation of various mammals, including mice, rabbits, and goats. During this procedure, an antigen is administered via injectable into the mammal body to activate the B-lymphocytes that supply IgG. These antibodies are used in labeling reagents in multiple immunoassay tests, including enzyme-linked immunosorbent assay (ELISA), western blot tests, immunoradiometric assay (IRMA), and radioimmunoassay (RIA). Apart from this, the process does not require skilled professionals to produce large batches of vaccinations. Mammalian polyclonal IgG antibody helps create multiple therapeutics, diagnose various ailments, and perform antibody identification and flow cytometry. As a result, they find extensive applications in biochemical research to detect denatured proteins and examine diseases and their treatments. At present, they are commercially available in cardiac, metabolic, and renal marker product variants.
Mammalian Polyclonal IgG Antibody Market Trends:
The increasing prevalence of various chronic disorders, including cancer and autoimmune ailments, and the rising need for antibodies for multiple immunoassay tests and therapeutic and analytical applications in research settings are primarily driving the market growth. In line with this, significant investments in biotechnology and pharmaceutical companies by governments to formulate effective novel vaccinations and injectables through advanced technologies are acting as another growth-inducing factor. Additionally, the ongoing innovation of creative mammalian antibodies by biopharma organizations for quality control (QC) is contributing to the market growth. Moreover, the escalating biomarkers approval and their extensive usage by clinicians for accurate and rapid diagnosis of B-cell lymphoma and leukemia are supporting the market growth. Apart from this, significant enhancements in the healthcare infrastructure and research and development (R&D) activities to enhance antibody efficacy are creating a positive outlook for the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global mammalian polyclonal IgG antibody market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on type, product, application and end use.
Breakup by Type:
Goat
Rabbit
Horse
Mouse
Others
Breakup by Product:
Cardiac Markers
Metabolic Markers
Renal Markers
Others
Breakup by Application:
ELISA
Immunoturbidimetry
Immunoelectrophoresis
Antibody Identification
Immunohistochemistry
Immunocytochemistry
Western Blotting
Breakup by End Use:
Hospitals
Diagnostic Centers
Academic and Research Institutes
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbiotec Inc., Abcam plc, Bio-Rad Laboratories Inc., Cell Signaling Technology Inc., Creative Diagnostics, Elabscience Biotechnology Inc., Geno Technology Inc., Merck KGaA, Proteintech Group Inc., STEMCELL Technologies Inc. and Thermo Fisher Scientific Inc.
Key Questions Answered in This Report:
How has the global mammalian polyclonal IgG antibody market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global mammalian polyclonal IgG antibody market?
What are the key regional markets?
What is the breakup of the market based on the type?
What is the breakup of the market based on the product?
What is the breakup of the market based on the application?
What is the breakup of the market based on the end use?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global mammalian polyclonal IgG antibody market and who are the key players?
What is the degree of competition in the industry?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Mammalian Polyclonal IgG Antibody Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Type
6.1 Goat
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Rabbit
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Horse
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Mouse
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Others
6.5.1 Market Trends
6.5.2 Market Forecast
7 Market Breakup by Product
7.1 Cardiac Markers
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Metabolic Markers
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Renal Markers
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Others
7.4.1 Market Trends
7.4.2 Market Forecast
8 Market Breakup by Application
8.1 ELISA
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Immunoturbidimetry
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Immunoelectrophoresis
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Antibody Identification
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Immunohistochemistry
8.5.1 Market Trends
8.5.2 Market Forecast
8.6 Immunocytochemistry
8.6.1 Market Trends
8.6.2 Market Forecast
8.7 Western Blotting
8.7.1 Market Trends
8.7.2 Market Forecast
9 Market Breakup by End Use
9.1 Hospitals
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Diagnostic Centers
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Academic and Research Institutes
9.3.1 Market Trends
9.3.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Abbiotec Inc.
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.2 Abcam plc
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.2.3 Financials
15.3.2.4 SWOT Analysis
15.3.3 Bio-Rad Laboratories Inc.
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 Financials
15.3.3.4 SWOT Analysis
15.3.4 Cell Signaling Technology Inc.
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.5 Creative Diagnostics
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.6 Elabscience Biotechnology Inc.
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.7 Geno Technology Inc.
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.8 Merck KGaA
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 Financials
15.3.8.4 SWOT Analysis
15.3.9 Proteintech Group Inc.
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.10 STEMCELL Technologies Inc.
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.11 Thermo Fisher Scientific Inc.
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.11.3 Financials
15.3.11.4 SWOT Analysis
Figure 2: Global: Mammalian Polyclonal IgG Antibody Market: Sales Value (in Million US$), 2016-2021
Figure 3: Global: Mammalian Polyclonal IgG Antibody Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 4: Global: Mammalian Polyclonal IgG Antibody Market: Breakup by Type (in %), 2021
Figure 5: Global: Mammalian Polyclonal IgG Antibody Market: Breakup by Product (in %), 2021
Figure 6: Global: Mammalian Polyclonal IgG Antibody Market: Breakup by Application (in %), 2021
Figure 7: Global: Mammalian Polyclonal IgG Antibody Market: Breakup by End Use (in %), 2021
Figure 8: Global: Mammalian Polyclonal IgG Antibody Market: Breakup by Region (in %), 2021
Figure 9: Global: Mammalian Polyclonal IgG Antibody (Goat) Market: Sales Value (in Million US$), 2016 & 2021
Figure 10: Global: Mammalian Polyclonal IgG Antibody (Goat) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 11: Global: Mammalian Polyclonal IgG Antibody (Rabbit) Market: Sales Value (in Million US$), 2016 & 2021
Figure 12: Global: Mammalian Polyclonal IgG Antibody (Rabbit) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 13: Global: Mammalian Polyclonal IgG Antibody (Horse) Market: Sales Value (in Million US$), 2016 & 2021
Figure 14: Global: Mammalian Polyclonal IgG Antibody (Horse) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 15: Global: Mammalian Polyclonal IgG Antibody (Mouse) Market: Sales Value (in Million US$), 2016 & 2021
Figure 16: Global: Mammalian Polyclonal IgG Antibody (Mouse) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 17: Global: Mammalian Polyclonal IgG Antibody (Other Types) Market: Sales Value (in Million US$), 2016 & 2021
Figure 18: Global: Mammalian Polyclonal IgG Antibody (Other Types) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 19: Global: Mammalian Polyclonal IgG Antibody (Cardiac Markers) Market: Sales Value (in Million US$), 2016 & 2021
Figure 20: Global: Mammalian Polyclonal IgG Antibody (Cardiac Markers) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 21: Global: Mammalian Polyclonal IgG Antibody (Metabolic Markers) Market: Sales Value (in Million US$), 2016 & 2021
Figure 22: Global: Mammalian Polyclonal IgG Antibody (Metabolic Markers) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 23: Global: Mammalian Polyclonal IgG Antibody (Renal Markers) Market: Sales Value (in Million US$), 2016 & 2021
Figure 24: Global: Mammalian Polyclonal IgG Antibody (Renal Markers) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 25: Global: Mammalian Polyclonal IgG Antibody (Other Products) Market: Sales Value (in Million US$), 2016 & 2021
Figure 26: Global: Mammalian Polyclonal IgG Antibody (Other Products) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 27: Global: Mammalian Polyclonal IgG Antibody (ELISA) Market: Sales Value (in Million US$), 2016 & 2021
Figure 28: Global: Mammalian Polyclonal IgG Antibody (ELISA) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 29: Global: Mammalian Polyclonal IgG Antibody (Immunoturbidimetry) Market: Sales Value (in Million US$), 2016 & 2021
Figure 30: Global: Mammalian Polyclonal IgG Antibody (Immunoturbidimetry) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 31: Global: Mammalian Polyclonal IgG Antibody (Immunoelectrophoresis) Market: Sales Value (in Million US$), 2016 & 2021
Figure 32: Global: Mammalian Polyclonal IgG Antibody (Immunoelectrophoresis) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 33: Global: Mammalian Polyclonal IgG Antibody (Antibody Identification) Market: Sales Value (in Million US$), 2016 & 2021
Figure 34: Global: Mammalian Polyclonal IgG Antibody (Antibody Identification) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 35: Global: Mammalian Polyclonal IgG Antibody (Immunohistochemistry) Market: Sales Value (in Million US$), 2016 & 2021
Figure 36: Global: Mammalian Polyclonal IgG Antibody (Immunohistochemistry) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 37: Global: Mammalian Polyclonal IgG Antibody (Immunocytochemistry) Market: Sales Value (in Million US$), 2016 & 2021
Figure 38: Global: Mammalian Polyclonal IgG Antibody (Immunocytochemistry) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 39: Global: Mammalian Polyclonal IgG Antibody (Western Blotting) Market: Sales Value (in Million US$), 2016 & 2021
Figure 40: Global: Mammalian Polyclonal IgG Antibody (Western Blotting) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 41: Global: Mammalian Polyclonal IgG Antibody (Hospitals) Market: Sales Value (in Million US$), 2016 & 2021
Figure 42: Global: Mammalian Polyclonal IgG Antibody (Hospitals) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 43: Global: Mammalian Polyclonal IgG Antibody (Diagnostic Centers) Market: Sales Value (in Million US$), 2016 & 2021
Figure 44: Global: Mammalian Polyclonal IgG Antibody (Diagnostic Centers) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 45: Global: Mammalian Polyclonal IgG Antibody (Academic and Research Institutes) Market: Sales Value (in Million US$), 2016 & 2021
Figure 46: Global: Mammalian Polyclonal IgG Antibody (Academic and Research Institutes) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 47: North America: Mammalian Polyclonal IgG Antibody Market: Sales Value (in Million US$), 2016 & 2021
Figure 48: North America: Mammalian Polyclonal IgG Antibody Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 49: United States: Mammalian Polyclonal IgG Antibody Market: Sales Value (in Million US$), 2016 & 2021
Figure 50: United States: Mammalian Polyclonal IgG Antibody Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 51: Canada: Mammalian Polyclonal IgG Antibody Market: Sales Value (in Million US$), 2016 & 2021
Figure 52: Canada: Mammalian Polyclonal IgG Antibody Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 53: Asia-Pacific: Mammalian Polyclonal IgG Antibody Market: Sales Value (in Million US$), 2016 & 2021
Figure 54: Asia-Pacific: Mammalian Polyclonal IgG Antibody Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 55: China: Mammalian Polyclonal IgG Antibody Market: Sales Value (in Million US$), 2016 & 2021
Figure 56: China: Mammalian Polyclonal IgG Antibody Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 57: Japan: Mammalian Polyclonal IgG Antibody Market: Sales Value (in Million US$), 2016 & 2021
Figure 58: Japan: Mammalian Polyclonal IgG Antibody Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 59: India: Mammalian Polyclonal IgG Antibody Market: Sales Value (in Million US$), 2016 & 2021
Figure 60: India: Mammalian Polyclonal IgG Antibody Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 61: South Korea: Mammalian Polyclonal IgG Antibody Market: Sales Value (in Million US$), 2016 & 2021
Figure 62: South Korea: Mammalian Polyclonal IgG Antibody Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 63: Australia: Mammalian Polyclonal IgG Antibody Market: Sales Value (in Million US$), 2016 & 2021
Figure 64: Australia: Mammalian Polyclonal IgG Antibody Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 65: Indonesia: Mammalian Polyclonal IgG Antibody Market: Sales Value (in Million US$), 2016 & 2021
Figure 66: Indonesia: Mammalian Polyclonal IgG Antibody Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 67: Others: Mammalian Polyclonal IgG Antibody Market: Sales Value (in Million US$), 2016 & 2021
Figure 68: Others: Mammalian Polyclonal IgG Antibody Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 69: Europe: Mammalian Polyclonal IgG Antibody Market: Sales Value (in Million US$), 2016 & 2021
Figure 70: Europe: Mammalian Polyclonal IgG Antibody Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 71: Germany: Mammalian Polyclonal IgG Antibody Market: Sales Value (in Million US$), 2016 & 2021
Figure 72: Germany: Mammalian Polyclonal IgG Antibody Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 73: France: Mammalian Polyclonal IgG Antibody Market: Sales Value (in Million US$), 2016 & 2021
Figure 74: France: Mammalian Polyclonal IgG Antibody Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 75: United Kingdom: Mammalian Polyclonal IgG Antibody Market: Sales Value (in Million US$), 2016 & 2021
Figure 76: United Kingdom: Mammalian Polyclonal IgG Antibody Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 77: Italy: Mammalian Polyclonal IgG Antibody Market: Sales Value (in Million US$), 2016 & 2021
Figure 78: Italy: Mammalian Polyclonal IgG Antibody Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 79: Spain: Mammalian Polyclonal IgG Antibody Market: Sales Value (in Million US$), 2016 & 2021
Figure 80: Spain: Mammalian Polyclonal IgG Antibody Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 81: Russia: Mammalian Polyclonal IgG Antibody Market: Sales Value (in Million US$), 2016 & 2021
Figure 82: Russia: Mammalian Polyclonal IgG Antibody Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 83: Others: Mammalian Polyclonal IgG Antibody Market: Sales Value (in Million US$), 2016 & 2021
Figure 84: Others: Mammalian Polyclonal IgG Antibody Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 85: Latin America: Mammalian Polyclonal IgG Antibody Market: Sales Value (in Million US$), 2016 & 2021
Figure 86: Latin America: Mammalian Polyclonal IgG Antibody Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 87: Brazil: Mammalian Polyclonal IgG Antibody Market: Sales Value (in Million US$), 2016 & 2021
Figure 88: Brazil: Mammalian Polyclonal IgG Antibody Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 89: Mexico: Mammalian Polyclonal IgG Antibody Market: Sales Value (in Million US$), 2016 & 2021
Figure 90: Mexico: Mammalian Polyclonal IgG Antibody Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 91: Others: Mammalian Polyclonal IgG Antibody Market: Sales Value (in Million US$), 2016 & 2021
Figure 92: Others: Mammalian Polyclonal IgG Antibody Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 93: Middle East and Africa: Mammalian Polyclonal IgG Antibody Market: Sales Value (in Million US$), 2016 & 2021
Figure 94: Middle East and Africa: Mammalian Polyclonal IgG Antibody Market: Breakup by Country (in %), 2021
Figure 95: Middle East and Africa: Mammalian Polyclonal IgG Antibody Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 96: Global: Mammalian Polyclonal IgG Antibody Industry: SWOT Analysis
Figure 97: Global: Mammalian Polyclonal IgG Antibody Industry: Value Chain Analysis
Figure 98: Global: Mammalian Polyclonal IgG Antibody Industry: Porter's Five Forces Analysis
